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 Epidemiological studies indicate that there may be an association between obstructive sleep apnea (OSA) and cardiovascularRational.
and metabolic diseases. Some pro-inflammatory miRs (miR-21, miR320) critical for the immune response or hypoxia are often
overexpressed in cancers and atherosclerosis.
 To examine the expression of miR-21& miR320 in circulating exosomes from patients with OSA.Aim.
 From a Sleep Unit and in the frame of a long-term longitudinal cohort study we selected 65 non-smokers OSA patientsMethods:
(apnea-hypopnea index –AHI- 30 events/h) and 26 age, gender and BMI-matched controls (AHI < 5). All participants were free of
comorbidities other than OSA at baseline (GovTrials, NCT014575421). At recruitment and yearly, carotid ultrasound was performed and
subclinical atherosclerosis (SA) was defined as by the presence of carotid plaques of by an intima-media thickness > 0.85 mm.
Plasma-derived exosomes were isolated by precipitation using miRCURY™ Exosome Isolation Kit. Exosomes were characterized by
transmission electron microscopy, dynamic light scattering assay and Western Blot analysis using CD63 and HSP70. Exosome total RNA
was obtained using miRCURY™ RNA isolation kit. miR-21-5p and miR-320-3p were analysed by real time quantitative PCR (RT-qPCR) using
miRCURY LNA™ technology.
Results:
At baseline, expression of both plasma exosomes miR-21-5p and miR-320a-3p were increased in patients with OSA compared to controls
(Fold Change (FC): 2.69 and 1,81 respectively (p<0.01)). FC expression was higher in the OSA patients with SA than in patients without SA:
2,47±2,19 vs 1,65±0,69 for miR21-5p (p<0.02) and 1,98±1,10 vs 1,46±0,72 (p<0.05) respectively. At one-year follow-up, expression of
320a-3p did not change in patients treated with CPAP (n=40) or non-treated (n=25) whatever the SA status was at baseline. However,
miR-21-5p showed a persistent overexpression among non-treated OSA patients with SA (3,77±3,71) and a decreased in patients treated
with CPAP (1,49±1,19, p <0.01).
 Circulating exosomes cargo of miR-21-5p and miR-320a-3p are increase in patients with OSA and subclinical atherosclerosis.Conclusions.
After one year of effective treatment with CPAP in OSA patients, circulating exosomal miR-21-5p decrease in those with subclinical
atherosclerosis. This study suggest that this miRNA may play a role as an intermediary mechanism in cardiovascular morbidity in OSA.
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